Author:
Lipkus Isaac M.,Vadaparampil Susan T.,Jacobsen Paul B.,Miree Cheryl A.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Oncology
Reference11 articles.
1. Harris L, Fritsche H, Mennel R et al (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25(33):5287–5312
2. National Comprehensive Cancer Network (2011). Practice guidelines in oncology for breast cancer (Version 2.2011). National Comprehensive Cancer Network, Inc.
3. Lo SS, Mumby PB, Norton J, Rychlik K, Smerage J, Kash J, Chew HK, Gaynor ER, et al. (2010) Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol 28(10):1671–1676.
4. American Cancer Society (2010) Breast cancer profiler tool. Accessed 17 February 2011
5. Goldstein LJ, Gray R, Badve S et al (2008) Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol 26(25):4063–4071
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献